The potential of GHK as an anti-aging peptide For Research & Development use only
95% of children exposed by 9 months Neurodevelopmental disorder prevalence: 1960s: 1 in 10,000 1980s: 1 in 2,000 Late 1990s: 1 in 200 2021: 1 in 44 1996-2010: 269% increase in prevalence 1998-2018: 787% increase in UK The dramatic rise began in the late 1980s and accelerated through the 1990s and 2000sapproximately 25-30 years after acetaminophen's widespread adoption in pregnancy
was supported by the New National Excellence Program of the Ministry for Innovation and Technology (NKP-23-3-SZTE-535)
Faster & logistically easier than the oral regimen
In our microbiological testing, we measure the aerobic mesophilic plate count (total plate count), as well as the levels of Escherichia coli (E
Unique Benefits: The copper component in GHK-Cu provides additional biological activity beyond what amino acids alone can achieve, including enhanced antioxidant effects and improved microcirculation through the promotion of angiogenesis